December 13, 2024 Joint Statement in Response to South African Competition Commission Decision to Drop Investigation Against Vertex Pharmaceuticals on Treatment for Cystic Fibrosis Fair Access, News & Opinions
December 12, 2024 FAQ: Gilead’s LENACAPAVIR (LEN-LA) license and implications for access Educational Material, Fair Access, Gilead License
December 2, 2024 Activist Coalition Demands Accelerated Access to Revolutionary HIV Prevention Fair Access, Gilead License, News & Opinions
July 5, 2024 MSF and Health Justice Initiative welcome J&J’s withdrawal of patents on lifesaving TB drug in South Africa Fair Access, News & Opinions
